# Study of Arginine Free IED in Critically Ill Patients.

> **NCT01713257** · PHASE4 · COMPLETED · sponsor: **Thai Otsuka Pharmaceutical Co., Ltd.** · enrollment: 172 (actual)

## Conditions studied

- Critical Illness

## Interventions

- **DIETARY_SUPPLEMENT:** Immunoenhancing diet
- **DIETARY_SUPPLEMENT:** Isocaloric, isonitrogenous diet

## Key facts

- **NCT ID:** NCT01713257
- **Lead sponsor:** Thai Otsuka Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 172 (ACTUAL)
- **Last updated:** 2012-10-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01713257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01713257, "Study of Arginine Free IED in Critically Ill Patients.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT01713257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*